Oxford Cancer Analytics is transforming curative cancer treatments through a minimally invasive blood test and machine learning.
We are on a mission to save lives and drastically improve cancer management through early detection, with machine learning and an affordable blood testJoin our team
Oxford Cancer Analytics focuses on strategic beachhead markets in lung cancer for expedited product deployment.
Applying state-of-the-art machine learning for multidimensional liquid biopsy data with a focus on protein enables maximised detection accuracy compared to leading competitors.
OXcan has international partnerships focussing on all aspects of lung cancer management, from high risk screening, to early recurrence detection and personalised treatment stratification.
Chief Executive Officer
President & Chief Operating Officer
Machine Learning Scientist
Partnerships and Development Manager
Medical Affairs and Regulatory Manager
Machine Learning Programmer
Learn more about our collaborationsFind out more
Ones to watch for 2021
1 in 10 annually
1 in 8 annually
3-5 Hythe Bridge Street
100 College St, Suite 150,